Psoriatic Arthritis Psa Treatment Market

Psoriatic Arthritis (PsA) Treatment Market: Patent Expiration of Blockbuster Disease Modifying Antirheumatic Drugs and Approval of Biosimilar Drugs to Propel Growth: Global Industry Analysis 2013 - 2017 and Opportunity Assessment 2018 - 2028

Ask The Analyst Customization Available Request Methodology

Leading Manufacturers of Biologics Hold More Than 56% Market Share

The psoriatic arthritis (PsA) treatment market is dominated by key manufacturers competing on the basis of different prices, and have different approved drugs and undergoing clinical trials for psoriatic arthritis (PsA) treatment market. Leading manufacturers in the psoriatic arthritis (PsA) treatment market are engaged in the research and development of biologics and biosimilars, along with expansion activities through partnerships, acquisitions, and collaborations.

AbbVie Inc., Novartis AG, Bristol-Myers Squibb Company, and other key companies in biologics hold more than 56% revenue share in the global psoriatic arthritis (PsA) treatment market. These companies are continuously making efforts to expand their product portfolios in the psoriatic arthritis (PsA) treatment market. Through collaborations, acquisitions, and partnerships, companies dealing in psoriatic arthritis (PsA) treatment are focusing on improving their regional footprints and developing new biologics and TNF inhibitors.

Development of New Oral Treatment

Oral treatment has emerged with a sophisticated approach for the treatment of psoriatic arthritis (PsA) treatment. The Food and Drug Administration (FDA) approved apremilast (Otezla, Celgene Corporation), the first selective inhibitor of phosphodiesterase 4 (PDE4) indicated for adults with active PsA, in March 2014. Otezla for psoriatic arthritis (PsA) treatment with or without concomitant DMARDs, compared with other oral treatment along with or without DMARDs, shows great improvement in the signs and symptoms of psoriatic arthritis (PsA). Otezla also offers patients and physicians a new psoriatic arthritis (PsA) treatment option, with the potential to help psoriatic arthritis (PsA) patients, which further increases the adoption of oral treatment, and significantly drives the market for psoriatic arthritis (PsA) treatment.

Flourishing Combination Treatment and Dual Inhibitors

TNF inhibitors and interlukin-17 inhibitors such as secukinumab seem to be a promising combination therapy for psoriatic arthritis (PsA) treatment. Recent pre-clinical investigations have shown that, the combination is significantly capable of reducing joint pathology in murine experimental arthritis. Hence, a future combination of TNF inhibitors with an anti-IL-17 antibody seems plausible, which is expected to significantly drive the psoriatic arthritis (PsA) treatment market.

Moreover, a new era of bi-specific antibodies is expected to push the market growth of psoriatic arthritis (PsA) treatment over the forecast period. For instance, Covagen AG is investigating a bi-specific antibody - COVA322 targeting TNF/IL-17 in a phase Ib/Iia clinical trial. AbbVie Inc. is investigating an ABT 122-an antibody with dual specificity binding both, TNF and IL-17, in a phase II clinical trial.

Biomarkers to Facilitate Diagnosis and Treatment

A number of potential biomarkers are under investigation for psoriatic arthritis (PsA) treatment, which include soluble markers (e.g., C-reactive protein, matrix metalloproteases), cell populations (e.g., osteoclast precursors, relevant T cell subsets), and tissue resident markers in the joints (e.g., RANKL) or skin.

Recent advances in the targeted biological therapy have allowed patients to experience remission from PsA and psoriasis. In addition, biomarkers can be used to monitor the development of adverse reactions to specific treatment modalities, which significantly fuels the growth of psoriatic arthritis (PsA) treatment market.

psoriatic arthritis psa treatment market

Competitive Landscape

This section of the report features the profiles of key players operating in the psoriatic arthritis (PsA) treatment market based on their differential strategies, market shares, product offerings, marketing approach, and company dashboard. Examples of some of the key players featured in this report include Pfizer Inc., Johnson & Johnson, AbbVie Inc., Amgen Inc., Bristol-Myers Squibb Company, UCB S.A., Eli Lilly & Co, Novartis AG, Celgene Corporation, and AstraZeneca PLC, among others.

Key manufacturers in the psoriatic arthritis (PsA) treatment market are focusing on developing new biologics drugs and biosimilars to enhance effectivity and patient compliance.

Definition

Psoriatic arthritis (PsA) (PsA) is a chronic condition that combines the sore, swollen joints of arthritis along with psoriasis. Psoriasis causes scaly patches, which are itchy on the skin and scalp. Psoriatic arthritis (PsA) is related to the immune system, like psoriasis. The immune response causes inflammation, which triggers joint pain, swelling, and stiffness. Inflammation affects the entire body and leads to permanent tissue and joint damage if not treated earlier and aggressively. Psoriatic arthritis (PsA) treatment includes NSAIDS, DMARDs, and biologics.

About the Report

The company conducted a research study on the psoriatic arthritis (PsA) treatment market for the forecast period 2018 to 2028. The report offers a comprehensive evaluation of the business opportunities prevailing in the psoriatic arthritis (PsA) treatment market, along with insights on the current trends and analysis on clinical trials.

Additional Questions Answered

Some of the additional questions addressed in this report on the psoriatic arthritis (PsA) treatment market-

  • What is the revenue potential of the psoriatic arthritis (PsA) treatment market across the regions of North America and Europe?

  • Who are the key competitors and what are their portfolios in the psoriatic arthritis (PsA) treatment market?

  • What are major challenges influencing the growth of the psoriatic arthritis (PsA) treatment market?

  • How is intervention from regulatory authority shaping the growth of the psoriatic arthritis (PsA) treatment market?

Research Methodology

The psoriatic arthritis (PsA) treatment market has been estimated based on the prevalence and incidence rate approach. The market was first calculated based on the prevalence and incidence rate for calculating the base population in different region/countries. Other qualitative factors analyzed during volume estimation include different treatment options and diagnosis rates, treatment rate and percentage adoption of currently available treatment options in various stages of the disease, to obtain target population. This information is further validated with rigorous primary research (including interviews, surveys, in-person interactions, and viewpoints of seasoned analysts) and secondary research (including verified paid sources, authentic trade journals, and resourceful databases). The research study also includes top trends and macro as well as micro economic factors shaping the psoriatic arthritis (PsA) treatment market. With this approach, the report anticipates the industry attractiveness of every major segment in the psoriatic arthritis (PsA) treatment over the forecast period.

A recent market study published by the company titled, 'Psoriatic Arthritis (PsA) Treatment Market: Global Industry Analysis 2013–2017 and Opportunity Assessment 2018–2028', consists of a comprehensive assessment of the most important market dynamics of this market. On conducting a thorough research on the historic as well as current growth parameters of the psoriatic arthritis (PsA) treatment market, the growth prospects of the market are obtained with maximum precision. The report features unique and salient factors that may have a huge impact on the development of the psoriatic arthritis (PsA) treatment market during the forecast period. It can help market players modify their manufacturing and marketing strategies in order to envisage maximum growth in the psoriatic arthritis (PsA) treatment market in the coming years. The report provides detailed information about the current and future growth prospects of the psoriatic arthritis (PsA) treatment market in the most comprehensive way for the better understanding of readers.

Chapter 01 – Executive Summary

The report commences with the executive summary of the psoriatic arthritis (PsA) treatment market, which includes a summary of the key findings and key statistics of the market. It also includes the market value (US$ million) estimates of the leading segments in the psoriatic arthritis (PsA) treatment market.

Chapter 02 – Market Overview

Readers can find a detailed taxonomy and the definition of the psoriatic arthritis (PsA) treatment market in this chapter, which will help them better understand the basic information about the psoriatic arthritis (PsA) treatment market dynamics, clinical trials, average cost of treatment, and key regulations that have been included in the report.

Chapter 03 – Psoriatic Arthritis (PsA) Treatment Market Analysis & Opportunity Assessment 2018-2028 by Product Type

Based on product type, the psoriatic arthritis (PsA) treatment market is segmented into nonsteroidal anti-inflammatory drugs, disease modifying antirheumatic drugs, and biologics. Disease modifying antirheumatic drugs are further sub-segmented into corticosteroids, antimalarial, methotrexate, and others. Biologics are further sub-segmented into TNF Inhibitors and interleukin inhibitors. In this chapter, readers can find information about the key trends and developments in the psoriatic arthritis (PsA) treatment market, and market attractiveness analysis based on product type for each region.

Chapter 04 – Psoriatic Arthritis (PsA) Treatment Market Analysis & Opportunity Assessment 2018-2028 by Distribution Channel

Based on distribution channel, the psoriatic arthritis (PsA) treatment market is segmented into hospital pharmacies, retail pharmacies, and mail order pharmacies. In this chapter, readers can find information about the key trends and developments in the psoriatic arthritis (PsA) treatment market, and market attractiveness analysis based on distribution channel for each region.

Chapter 05 – Psoriatic Arthritis (PsA) Treatment Market Analysis & Opportunity Assessment 2018-2028 by Route of Administration

Based on route of administration, the psoriatic arthritis (PsA) treatment market is segmented into oral and injectable. In this chapter, readers can find information about the key trends and developments in the psoriatic arthritis (PsA) treatment market, and market attractiveness analysis based on route of administration in each region.

Chapter 06 – Psoriatic Arthritis (PsA) Treatment Market Analysis & Opportunity Assessment 2018-2028 by Region

This chapter explains how the psoriatic arthritis (PsA) treatment market will grow across various geographic regions such as North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa (MEA).

Chapter 07 – North America Psoriatic Arthritis (PsA) Treatment Market Analysis & Opportunity Assessment 2018-2028

This chapter includes detailed analysis of the growth of the North America psoriatic arthritis (PsA) treatment market, along with a country-wise assessment that includes the U.S. and Canada. Readers can also find regional trends, regulations, and market growth based on product type, route of administration, distribution channel, and country in the psoriatic arthritis (PsA) treatment market of North America.

Chapter 08 – Latin America Psoriatic Arthritis (PsA) Treatment Market Analysis & Opportunity Assessment 2018-2028

Readers can find detailed information about factors such as regional trends that are impacting the growth of the Latin America psoriatic arthritis (PsA) treatment market. This chapter also includes the growth prospects of the psoriatic arthritis (PsA) treatment market in leading LATAM countries such as Mexico, Brazil, and the rest of the Latin American region.

Chapter 09 – Europe Psoriatic Arthritis (PsA) Treatment Market Analysis & Opportunity Assessment 2018-2028

Important growth prospects of the psoriatic arthritis (PsA) treatment market based on its product type, distribution channel, and route of administration in several countries such as the U.K., Germany, Spain, Italy, France, Russia, and the rest of Europe are included in this chapter.

Chapter 10 – APAC Psoriatic Arthritis (PsA) Treatment Market Analysis & Opportunity Assessment 2018-2028

Japan, India, China, Australia, and the rest of APAC are the leading countries in the APAC region that are the prime subject of assessment to obtain the growth prospects of the APEC psoriatic arthritis (PsA) treatment market, in this chapter. Readers can find thorough information about the growth parameters of the APAC psoriatic arthritis (PsA) treatment market during the period 2018-2028.

Chapter 11 – MEA Psoriatic Arthritis (PsA) Treatment Market Analysis & Opportunity Assessment 2018-2028

This chapter provides information on how the psoriatic arthritis (PsA) treatment market will grow in major countries in the MEA region, such as GCC countries, South Africa, and the rest of MEA, during the period 2018-2028.

Chapter 12 – Competition Landscape, Company Share, and Company Profiles

In this chapter, readers can find a comprehensive list of all the leading stakeholders in the psoriatic arthritis (PsA) treatment market, along with detailed information about each company, including company overview, revenue shares, strategic overview, and recent company developments. The market players that have been featured in the report include Pfizer Inc., Johnson & Johnson, AbbVie Inc., Amgen Inc., Bristol-Myers Squibb Company, UCB S.A., Eli Lilly & Co, Novartis AG, Celgene Corporation, and AstraZeneca PLC, among others.

Chapter 13 – Assumptions and Acronyms

This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the report.

Chapter 14 – Research Methodology

This chapter helps readers understand the research methodology that is followed to obtain various conclusions, important qualitative information, and quantitative information about the psoriatic arthritis (PsA) treatment market.

Psoriatic Arthritis Psa Treatment Market Reports - Table of Contents

  1. Executive Summary

    • Market Overview

    • Market Analysis

    • FMI Analysis and Recommendations

    • Wheel of Fortune

  2. Market Introduction

    • Market Taxonomy

    • Market Definition

  3. Global Psoriatic Arthritis Treatment Market Opportunity Analysis

    • Macro-Economic Factors

    • Opportunity Analysis

  4. Market Background

    • Market Dynamics

      • Drivers

      • Restraints

      • Trends

  5. Key Inclusions

    • Regulatory Scenario

    • Pipeline Analysis

  6. North America Psoriatic Arthritis Treatment Market Analysis 2013-2017 and Forecast 2018–2028

    • Introduction

    • Historical Market Size (US$ Mn) Analysis By Country, 2013-2017

      • U.S.

      • Canada

    • Market Size (US$ Mn) Forecast By Country, 2018–2028

    • Historical Market Size (US$ Mn) Analysis By Product Type, 2013-2017

      • Nonsteriodal Anti-inflammatory Drugs

      • Disease Modifying Antirheumatic Drugs

        • Corticosteriods

        • Antimalarials

        • Methotrexate

        • Others

      • Biologics

        • TNF Inhibitors

        • Interleukin Inhibitors

    • Market Size (US$ Mn) Forecast By Product Type, 2018–2028

    • Historical Market Size (US$ Mn) Analysis By Route of Administration, 2013-2017

      • Oral

      • Injectable

    • Market Size (US$ Mn) Forecast By Route of Administration, 2018–2028

    • Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013-2017

      • Hospital Pharmacies

      • Retail Pharmacies

      • Mail Order Pharmacies

    • Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2028

    • Market Attractiveness Analysis

      • By Country

      • By Product Type

      • By Route of Administration

      • By Distribution Channel

    • Drivers and Restraints: Impact Analysis

  7. Latin America Psoriatic Arthritis Treatment Market Analysis 2013-2017 and Forecast 2018–2028

    • Introduction

    • Historical Market Size (US$ Mn) Analysis By Country, 2013-2017

      • Brazil

      • Mexico

      • Rest of Latin America

    • Market Size (US$ Mn) Forecast By Country, 2018–2028

    • Historical Market Size (US$ Mn) Analysis By Product Type, 2013-2017

      • Nonsteriodal Anti-inflammatory Drugs

      • Disease Modifying Antirheumatic Drugs

        • Corticosteriods

        • Antimalarials

        • Methotrexate

        • Others

      • Biologics

        • TNF Inhibitors

        • Interleukin Inhibitors

    • Market Size (US$ Mn) Forecast By Product Type, 2018–2028

    • Historical Market Size (US$ Mn) Analysis By Route of Administration, 2013-2017

      • Oral

      • Injectable

    • Market Size (US$ Mn) Forecast By Route of Administration, 2018–2028

    • Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013-2017

      • Hospital Pharmacies

      • Retail Pharmacies

      • Mail Order Pharmacies

    • Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2028

    • Market Attractiveness Analysis

      • By Country

      • By Product Type

      • By Route of Administration

      • By Distribution Channel

    • Drivers and Restraints: Impact Analysis

  8. Europe Psoriatic Arthritis Treatment Market Analysis 2013-2017 and Forecast 2018–2028

    • Introduction

    • Historical Market Size (US$ Mn) Analysis By Country, 2013-2017

      • U.K.

      • France

      • Italy

      • Spain

      • Russia

      • Germany

      • Rest of Europe

    • Market Size (US$ Mn) Forecast By Country, 2018–2028

    • Historical Market Size (US$ Mn) Analysis By Product Type, 2013-2017

      • Nonsteriodal Anti-inflammatory Drugs

      • Disease Modifying Antirheumatic Drugs

        • Corticosteriods

        • Antimalarials

        • Methotrexate

        • Others

      • Biologics

        • TNF Inhibitors

        • Interleukin Inhibitors

    • Market Size (US$ Mn) Forecast By Product Type, 2018–2028

    • Historical Market Size (US$ Mn) Analysis By Route of Administration, 2013-2017

      • Oral

      • Injectable

    • Market Size (US$ Mn) Forecast By Route of Administration, 2018–2028

    • Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013-2017

      • Hospital Pharmacies

      • Retail Pharmacies

      • Mail Order Pharmacies

    • Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2028

    • Market Attractiveness Analysis

      • By Country

      • By Product Type

      • By Route of Administration

      • By Distribution Channel

    • Drivers and Restraints: Impact Analysis

  9. Asia-Pacific Psoriatic Arthritis Treatment Market Analysis 2013-2017 and Forecast 2018–2028

    • Introduction

    • Historical Market Size (US$ Mn) Analysis By Country, 2013-2017

      • Japan

      • China

      • India

      • Australia

      • Rest of APAC

    • Market Size (US$ Mn) Forecast By Country, 2018–2028

    • Historical Market Size (US$ Mn) Analysis By Product Type, 2013-2017

      • Nonsteriodal Anti-inflammatory Drugs

      • Disease Modifying Antirheumatic Drugs

        • Corticosteriods

        • Antimalarials

        • Methotrexate

        • Others

      • Biologics

        • TNF Inhibitors

        • Interleukin Inhibitors

    • Market Size (US$ Mn) Forecast By Product Type, 2018–2028

    • Historical Market Size (US$ Mn) Analysis By Route of Administration, 2013-2017

      • Oral

      • Injectable

    • Market Size (US$ Mn) Forecast By Route of Administration, 2018–2028

    • Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013-2017

      • Hospital Pharmacies

      • Retail Pharmacies

      • Mail Order Pharmacies

    • Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2028

    • Market Attractiveness Analysis

      • By Country

      • By Product Type

      • By Route of Administration

      • By Distribution Channel

    • Drivers and Restraints: Impact Analysis

  10. Middle East and Africa Psoriatic Arthritis Treatment Market Analysis 2013-2017 and Forecast 2018–2028

    • Introduction

    • Historical Market Size (US$ Mn) Analysis By Country, 2013-2017

      • GCC Countries

      • South Africa

      • Rest of MEA

    • Market Size (US$ Mn) Forecast By Country, 2018–2028

    • Historical Market Size (US$ Mn) Analysis By Product Type, 2013-2017

      • Nonsteriodal Anti-inflammatory Drugs

      • Disease Modifying Antirheumatic Drugs

        • Corticosteriods

        • Antimalarials

        • Methotrexate

        • Others

      • Biologics

        • TNF Inhibitors

        • Interleukin Inhibitors

    • Market Size (US$ Mn) Forecast By Product Type, 2018–2028

    • Historical Market Size (US$ Mn) Analysis By Route of Administration, 2013-2017

      • Oral

      • Injectable

    • Market Size (US$ Mn) Forecast By Route of Administration, 2018–2028

    • Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013-2017

      • Hospital Pharmacies

      • Retail Pharmacies

      • Mail Order Pharmacies

    • Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2028

    • Market Attractiveness Analysis

      • By Country

      • By Product Type

      • By Route of Administration

      • By Distribution Channel

    • Drivers and Restraints: Impact Analysis

  11. Forecast Factors: Relevance and Impact

  12. Forecast Assumptions

  13. Competition Analysis

    • Competition Dashboard

    • Competitors Deep Dive

      • Pfizer Inc.

        • Overview

        • Product Portfolio

        • Production Footprint

        • Sales Footprint

        • Channel Footprint

        • Strategy

          • Marketing Strategy

          • Product Strategy

          • Channel Strategy

      • Johnson & Johnson Services, Inc.

        • Product Portfolio

        • Production Footprint

        • Sales Footprint

        • Channel Footprint

        • Strategy

          • Marketing Strategy

          • Product Strategy

          • Channel Strategy

      • AbbVie Inc.

        • Overview

        • Product Portfolio

        • Production Footprint

        • Sales Footprint

        • Channel Footprint

        • Strategy

          • Marketing Strategy

          • Product Strategy

          • Channel Strategy

      • Amgen Inc.

        • Overview

        • Product Portfolio

        • Production Footprint

        • Sales Footprint

        • Channel Footprint

        • Strategy

          • Marketing Strategy

          • Product Strategy

          • Channel Strategy

      • Bristol-Myers Squibb Company

        • Overview

        • Product Portfolio

        • Production Footprint

        • Sales Footprint

        • Channel Footprint

        • Strategy

          • Marketing Strategy

          • Product Strategy

          • Channel Strategy

      • UCB S.A.

        • Overview

        • Product Portfolio

        • Production Footprint

        • Sales Footprint

        • Channel Footprint

        • Strategy

          • Marketing Strategy

          • Product Strategy

          • Channel Strategy

      • Eli Lilly & Co

        • Overview

        • Product Portfolio

        • Production Footprint

        • Sales Footprint

        • Channel Footprint

        • Strategy

          • Marketing Strategy

          • Product Strategy

          • Channel Strategy

      • Novartis AG

        • Overview

        • Product Portfolio

        • Production Footprint

        • Sales Footprint

        • Channel Footprint

        • Strategy

          • Marketing Strategy

          • Product Strategy

          • Channel Strategy

      • Celgene Corporation

        • Overview

        • Product Portfolio

        • Production Footprint

        • Sales Footprint

        • Channel Footprint

        • Strategy

          • Marketing Strategy

          • Product Strategy

          • Channel Strategy

      • AstraZeneca PLC

        • Overview

        • Product Portfolio

        • Production Footprint

        • Sales Footprint

        • Channel Footprint

        • Strategy

          • Marketing Strategy

          • Product Strategy

          • Channel Strategy

  14. Global Psoriatic Arthritis Treatment Market Analysis 2013-2017 and Forecast 2018–2028 By Region

    • Introduction / Key Findings

    • Historical Market Size (US$ Mn) Analysis By Region

      • North America

      • Europe

      • Latin America

      • Asia Pacific

      • Middle East and Africa

    • Market Size (US$ Mn) Forecast By Region

    • Market Attractiveness Analysis By Region

  15. Global Psoriatic Arthritis Treatment Market Analysis 2013-2017 and Forecast 2018–2028, By Product Type

    • Introduction/Key Finding

    • Historical Market Size (US$ Mn) Analysis By Product Type, 2013-2017

      • Nonsteriodal Anti-inflammatory Drugs

      • Disease Modifying Antirheumatic Drugs

        • Corticosteriods

        • Antimalarials

        • Methotrexate

        • Others

      • Biologics

        • TNF Inhibitors

        • Interleukin Inhibitors

    • Market Size (US$ Mn) Forecast By Product Type, 2018–2028

    • Market Attractiveness Analysis By Product Type

  16. Global Psoriatic Arthritis Treatment Market Analysis 2013-2017 and Forecast 2018–2028, By Route of Administration

    • Introduction/Key Finding

    • Historical Market Size (US$ Mn) Analysis By Product Type, 2013-2017

      • Oral

      • Injectable

    • Market Size (US$ Mn) Forecast By Product Type, 2018–2028

    • Market Attractiveness Analysis By Product Type

  17. Global Psoriatic Arthritis Treatment Market Analysis 2013-2017 and Forecast 2018–2028, By Distribution Channel

    • Introduction/Key Finding

    • Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2013-2017

      • Hospital Pharmacies

      • Retail Pharmacies

      • Mail Order Pharmacies

    • Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2028

    • Market Attractiveness Analysis By Distribution Channel

  18. Global Psoriatic Arthritis Treatment Market Analysis 2013-2017 and Forecast 2018–2028

    • Market Value Share Analysis By All Segment

    • Y-o-Y Growth Analysis By All Segment

    • Absolute $ Opportunity

  19. Assumptions and Acronyms Used

  20. Research Methodology

Psoriatic Arthritis Psa Treatment Market Reports - List of Tables

  1. North America Psoriatic Arthritis Treatment Market size (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, By Country

  2. North America Psoriatic Arthritis Treatment Market Size (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, Product Type

  3. North America Psoriatic Arthritis Treatment Market Size (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, By Route of Administration

  4. North America Psoriatic Arthritis Treatment Market size (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, By Distribution Channel

  5. Latin America Psoriatic Arthritis Treatment Market size (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, By Country

  6. Latin America Psoriatic Arthritis Treatment Market Size (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, Product Type

  7. Latin America Psoriatic Arthritis Treatment Market Size (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, By Route of Administration

  8. Latin America Psoriatic Arthritis Treatment Market size (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, By Distribution Channel

  9. Europe Psoriatic Arthritis Treatment Market size (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, By Country

  10. Europe Psoriatic Arthritis Treatment Market Size (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, Product Type

  11. Europe Psoriatic Arthritis Treatment Market Size (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, By Route of Administration

  12. Europe Psoriatic Arthritis Treatment Market size (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, By Distribution Channel

  13. Asia Pacific Psoriatic Arthritis Treatment Market size (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, By Country

  14. Asia Pacific Psoriatic Arthritis Treatment Market Size (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, Product Type

  15. Asia Pacific Psoriatic Arthritis Treatment Market Size (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, By Route of Administration

  16. Asia Pacific Psoriatic Arthritis Treatment Market size (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, By Distribution Channel

  17. Middle East & Africa Psoriatic Arthritis Treatment Market size (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, By Country

  18. Middle East & Africa Psoriatic Arthritis Treatment Market Size (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, Product Type

  19. Middle East & Africa Psoriatic Arthritis Treatment Market Size (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, By Route of Administration

  20. Middle East & Africa Psoriatic Arthritis Treatment Market size (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, By Distribution Channel

  21. Global Psoriatic Arthritis Treatment Market Size (US$ Mn) Forecast By Region, 2012–2017

  22. Global Psoriatic Arthritis Treatment Market Size Value (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Product Type

  23. Global Psoriatic Arthritis Treatment Market Size Value (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Route of Administration

  24. Global Psoriatic Arthritis Treatment Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Distribution Channel

Psoriatic Arthritis Psa Treatment Market Reports - List of Figures

  1. Global Psoriatic Arthritis Treatment Market Value Share By Product Type (2018E)

  2. Global Psoriatic Arthritis Treatment Market Value Share By Route of Administration (2018E)

  3. Global Psoriatic Arthritis Treatment Market Value Share By Distribution Channel (2018E)

  4. Global Psoriatic Arthritis Treatment Market Value Share By Region (2018E)

  5. North America Psoriatic Arthritis Treatment Market Value Share By Product Type (2018E)

  6. North America Psoriatic Arthritis Treatment Market Value Share By Route of Administration (2018E)

  7. North America Psoriatic Arthritis Treatment Market Value Share By Distribution Channel (2018E)

  8. North America Psoriatic Arthritis Treatment Market Value Share By Country (2018E)

  9. North America Psoriatic Arthritis Treatment Market Size Analysis, 2013–2017

  10. North America Psoriatic Arthritis Treatment Market Forecast & Y-o-Y growth, 2018–2028

  11. U.S. Psoriatic Arthritis Treatment Market Size (US$ Mn) Analysis, 2013–2017

  12. U.S. Psoriatic Arthritis Treatment Market Forecast & Y-o-Y Growth (%), 2017-2028

  13. Canada Psoriatic Arthritis Treatment Market Size (US$ Mn) Analysis, 2013–2017

  14. Canada Psoriatic Arthritis Treatment Market Forecast & Y-o-Y Growth (%), 2017-2028

  15. North America Nonsteroidal Anti-Inflammatory Drugs Market Size (US$ Mn) Analysis, 2013–2017

  16. North America Nonsteroidal Anti-Inflammatory Drugs Market Forecast & Y-o-Y Growth (%), 2017-2028

  17. North America Disease-Modifying Antirheumatic Drugs (DMARDs) Market Size (US$ Mn) Analysis, 2013–2017

  18. North America Disease-Modifying Antirheumatic Drugs (DMARDs) Market Forecast & Y-o-Y Growth (%), 2017-2028

  19. North America Biologics Market Size (US$ Mn) Analysis, 2013–2017

  20. North America Biologics Market Forecast & Y-o-Y Growth (%), 2017-2028

  21. North America Psoriatic Arthritis Treatment Market Attractiveness Analysis By Product Type, 2018–2028

  22. North America Psoriatic Arthritis Treatment Market Attractiveness Analysis By Route of Administration, 2018–2028

  23. North America Psoriatic Arthritis Treatment Market Attractiveness Analysis By Distribution Channel, 2018–2028

  24. North America Psoriatic Arthritis Treatment Market Attractiveness Analysis By Country, 2018–2028

  25. Latin America Psoriatic Arthritis Treatment Market Value Share By Product Type (2018E)

  26. Latin America Psoriatic Arthritis Treatment Market Value Share By Route of Administration (2018E)

  27. Latin America Psoriatic Arthritis Treatment Market Value Share By Distribution Channel (2018E)

  28. Latin America Psoriatic Arthritis Treatment Market Value Share By Country (2018E)

  29. Latin America Psoriatic Arthritis Treatment Market Size Analysis, 2013–2017

  30. Latin America Psoriatic Arthritis Treatment Market Forecast & Y-o-Y growth, 2018–2028

  31. Mexico Psoriatic Arthritis Treatment Market Size (US$ Mn) Analysis, 2013–2017

  32. Mexico Psoriatic Arthritis Treatment Market Forecast & Y-o-Y Growth (%), 2017-2028

  33. Brazil Psoriatic Arthritis Treatment Market Size (US$ Mn) Analysis, 2013–2017

  34. Brazil Psoriatic Arthritis Treatment Market Forecast & Y-o-Y Growth (%), 2017-2028

  35. Rest of Latin America Psoriatic Arthritis Treatment Market Size (US$ Mn) Analysis, 2013–2017

  36. Rest of Latin America Psoriatic Arthritis Treatment Market Forecast & Y-o-Y Growth (%), 2017-2028

  37. Latin America Nonsteroidal Anti-Inflammatory Drugs Market Size (US$ Mn) Analysis, 2013–2017

  38. Latin America Nonsteroidal Anti-Inflammatory Drugs Market Forecast & Y-o-Y Growth (%), 2017-2028

  39. Latin America Disease-Modifying Antirheumatic Drugs (DMARDs) Market Size (US$ Mn) Analysis, 2013–2017

  40. Latin America Disease-Modifying Antirheumatic Drugs (DMARDs) Market Forecast & Y-o-Y Growth (%), 2017-2028

  41. Latin America Biologics Market Size (US$ Mn) Analysis, 2013–2017

  42. Latin America Biologics Market Forecast & Y-o-Y Growth (%), 2017-2028

  43. Latin America Psoriatic Arthritis Treatment Market Attractiveness Analysis By Product Type, 2018–2028

  44. Latin America Psoriatic Arthritis Treatment Market Attractiveness Analysis By Route of Administration, 2018–2028

  45. Latin America Psoriatic Arthritis Treatment Market Attractiveness Analysis By Distribution Channel, 2018–2028

  46. Latin America Psoriatic Arthritis Treatment Market Attractiveness Analysis By Country, 2018–2028

  47. Europe Psoriatic Arthritis Treatment Market Value Share By Product Type (2018E)

  48. Europe Psoriatic Arthritis Treatment Market Value Share By Route of Administration (2018E)

  49. Europe Psoriatic Arthritis Treatment Market Value Share By Distribution Channel (2018E)

  50. Europe Psoriatic Arthritis Treatment Market Value Share By Country (2018E)

  51. Europe Psoriatic Arthritis Treatment Market Size Analysis, 2013–2017

  52. Europe Psoriatic Arthritis Treatment Market Forecast & Y-o-Y growth, 2018–2028

  53. U.K. Psoriatic Arthritis Treatment Market Size (US$ Mn) Analysis, 2013–2017

  54. U.K. Psoriatic Arthritis Treatment Market Forecast & Y-o-Y Growth (%), 2017-2028

  55. France Psoriatic Arthritis Treatment Market Size (US$ Mn) Analysis, 2013–2017

  56. France Psoriatic Arthritis Treatment Market Forecast & Y-o-Y Growth (%), 2017-2028

  57. Italy Psoriatic Arthritis Treatment Market Size (US$ Mn) Analysis, 2013–2017

  58. Italy Psoriatic Arthritis Treatment Market Forecast & Y-o-Y Growth (%), 2017-2028

  59. Spain Psoriatic Arthritis Treatment Market Size (US$ Mn) Analysis, 2013–2017

  60. Spain Psoriatic Arthritis Treatment Market Forecast & Y-o-Y Growth (%), 2017-2028

  61. Russia Psoriatic Arthritis Treatment Market Size (US$ Mn) Analysis, 2013–2017

  62. Russia Psoriatic Arthritis Treatment Market Forecast & Y-o-Y Growth (%), 2017-2028

  63. Germany Psoriatic Arthritis Treatment Market Size (US$ Mn) Analysis, 2013–2017

  64. Germany Psoriatic Arthritis Treatment Market Forecast & Y-o-Y Growth (%), 2017-2028

  65. Rest of Europe Psoriatic Arthritis Treatment Market Size (US$ Mn) Analysis, 2013–2017

  66. Rest of Europe Psoriatic Arthritis Treatment Market Forecast & Y-o-Y Growth (%), 2017-2028

  67. Europe Nonsteroidal Anti-Inflammatory Drugs Market Size (US$ Mn) Analysis, 2013–2017

  68. Europe Nonsteroidal Anti-Inflammatory Drugs Market Forecast & Y-o-Y Growth (%), 2017-2028

  69. Europe Disease-Modifying Antirheumatic Drugs (DMARDs) Market Size (US$ Mn) Analysis, 2013–2017

  70. Europe Disease-Modifying Antirheumatic Drugs (DMARDs) Market Forecast & Y-o-Y Growth (%), 2017-2028

  71. Europe Biologics Market Size (US$ Mn) Analysis, 2013–2017

  72. Europe Biologics Market Forecast & Y-o-Y Growth (%), 2017-2028

  73. Europe Psoriatic Arthritis Treatment Market Attractiveness Analysis By Product Type, 2018–2028

  74. Europe Psoriatic Arthritis Treatment Market Attractiveness Analysis By Route of Administration, 2018–2028

  75. Europe Psoriatic Arthritis Treatment Market Attractiveness Analysis By Distribution Channel, 2018–2028

  76. Europe Psoriatic Arthritis Treatment Market Attractiveness Analysis By Country, 2018–2028

  77. Asia Pacific Psoriatic Arthritis Treatment Market Value Share By Product Type (2018E)

  78. Asia Pacific Psoriatic Arthritis Treatment Market Value Share By Route of Administration (2018E)

  79. Asia Pacific Psoriatic Arthritis Treatment Market Value Share By Distribution Channel (2018E)

  80. Asia Pacific Psoriatic Arthritis Treatment Market Value Share By Country (2018E)

  81. Asia Pacific Psoriatic Arthritis Treatment Market Size Analysis, 2013–2017

  82. Asia Pacific Psoriatic Arthritis Treatment Market Forecast & Y-o-Y growth, 2018–2028

  83. Japan Psoriatic Arthritis Treatment Market Size (US$ Mn) Analysis, 2013–2017

  84. Japan Psoriatic Arthritis Treatment Market Forecast & Y-o-Y Growth (%), 2017-2028

  85. China Psoriatic Arthritis Treatment Market Size (US$ Mn) Analysis, 2013–2017

  86. China Psoriatic Arthritis Treatment Market Forecast & Y-o-Y Growth (%), 2017-2028

  87. India Psoriatic Arthritis Treatment Market Size (US$ Mn) Analysis, 2013–2017

  88. India Psoriatic Arthritis Treatment Market Forecast & Y-o-Y Growth (%), 2017-2028

  89. Australia Psoriatic Arthritis Treatment Market Size (US$ Mn) Analysis, 2013–2017

  90. Australia Psoriatic Arthritis Treatment Market Forecast & Y-o-Y Growth (%), 2017-2028

  91. Rest of Asia Pacific Psoriatic Arthritis Treatment Market Size (US$ Mn) Analysis, 2013–2017

  92. Rest of Asia Pacific Psoriatic Arthritis Treatment Market Forecast & Y-o-Y Growth (%), 2017-2028

  93. Asia Pacific Nonsteroidal Anti-Inflammatory Drugs Market Size (US$ Mn) Analysis, 2013–2017

  94. Asia Pacific Nonsteroidal Anti-Inflammatory Drugs Market Forecast & Y-o-Y Growth (%), 2017-2028

  95. Asia Pacific Disease-Modifying Antirheumatic Drugs (DMARDs) Market Size (US$ Mn) Analysis, 2013–2017

  96. Asia Pacific Disease-Modifying Antirheumatic Drugs (DMARDs) Market Forecast & Y-o-Y Growth (%), 2017-2028

  97. Asia Pacific Biologics Market Size (US$ Mn) Analysis, 2013–2017

  98. Asia Pacific Biologics Market Forecast & Y-o-Y Growth (%), 2017-2028

  99. Asia Pacific Psoriatic Arthritis Treatment Market Attractiveness Analysis By Product Type, 2018–2028

  100. Asia Pacific Psoriatic Arthritis Treatment Market Attractiveness Analysis By Route of Administration, 2018–2028

  101. Asia Pacific Psoriatic Arthritis Treatment Market Attractiveness Analysis By Distribution Channel, 2018–2028

  102. Asia Pacific Psoriatic Arthritis Treatment Market Attractiveness Analysis By Country, 2018–2028

  103. Middle East & Africa Psoriatic Arthritis Treatment Market Value Share By Product Type (2018E)

  104. Middle East & Africa Psoriatic Arthritis Treatment Market Value Share By Route of Administration (2018E)

  105. Middle East & Africa Psoriatic Arthritis Treatment Market Value Share By Distribution Channel (2018E)

  106. Middle East & Africa Psoriatic Arthritis Treatment Market Value Share By Country (2018E)

  107. Middle East & Africa Psoriatic Arthritis Treatment Market Size Analysis, 2013–2017

  108. Middle East & Africa Psoriatic Arthritis Treatment Market Forecast & Y-o-Y growth, 2018–2028

  109. South Africa Psoriatic Arthritis Treatment Market Size (US$ Mn) Analysis, 2013–2017

  110. South Africa Psoriatic Arthritis Treatment Market Forecast & Y-o-Y Growth (%), 2017-2028

  111. GCC Countries Psoriatic Arthritis Treatment Market Size (US$ Mn) Analysis, 2013–2017

  112. GCC Countries Psoriatic Arthritis Treatment Market Forecast & Y-o-Y Growth (%), 2017-2028

  113. Rest of Middle East & Africa Psoriatic Arthritis Treatment Market Size (US$ Mn) Analysis, 2013–2017

  114. Rest of Middle East & Africa Psoriatic Arthritis Treatment Market Forecast & Y-o-Y Growth (%), 2017-2028

  115. Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs Market Size (US$ Mn) Analysis, 2013–2017

  116. Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs Market Forecast & Y-o-Y Growth (%), 2017-2028

  117. Middle East & Africa Disease-Modifying Antirheumatic Drugs (DMARDs) Market Size (US$ Mn) Analysis, 2013–2017

  118. Middle East & Africa Disease-Modifying Antirheumatic Drugs (DMARDs) Market Forecast & Y-o-Y Growth (%), 2017-2028

  119. Middle East & Africa Biologics Market Size (US$ Mn) Analysis, 2013–2017

  120. Middle East & Africa Biologics Market Forecast & Y-o-Y Growth (%), 2017-2028

  121. Middle East & Africa Psoriatic Arthritis Treatment Market Attractiveness Analysis By Product Type, 2018–2028

  122. Middle East & Africa Psoriatic Arthritis Treatment Market Attractiveness Analysis By Route of Administration, 2018–2028

  123. Middle East & Africa Psoriatic Arthritis Treatment Market Attractiveness Analysis By Distribution Channel, 2018–2028

  124. Middle East & Africa Psoriatic Arthritis Treatment Market Attractiveness Analysis By Country, 2018–2028

  125. Global Psoriatic Arthritis Treatment Market Share Analysis (%) By Region, 2018 & 2028

  126. Global Psoriatic Arthritis Treatment Market Y-o-Y Growth (%) By Region, 2018–2028

  127. Global Psoriatic Arthritis Treatment Market Attractiveness Analysis By Region, 2018–2028

  128. Global Psoriatic Arthritis Treatment Market Share Analysis (%) By Product Type, 2018 & 2028

  129. Global Psoriatic Arthritis Treatment Market Y-o-Y Growth (%) By Product Type, 2018–2028

  130. Global Psoriatic Arthritis Treatment Market Attractiveness Analysis By Product Type, 2018–2028

  131. Global Psoriatic Arthritis Treatment Market Share Analysis (%) By Route of Administration , 2018 & 2028

  132. Global Psoriatic Arthritis Treatment Market Y-o-Y Growth (%) By Route of Administration , 2018–2028

  133. Global Psoriatic Arthritis Treatment Market Attractiveness Analysis By Route of Administration , 2018–2028

  134. Global Psoriatic Arthritis Treatment Market Share Analysis (%) By Distribution Channel, 2018 & 2028

  135. Global Psoriatic Arthritis Treatment Market Y-o-Y Growth (%) By Distribution Channel, 2018–2028

  136. Global Psoriatic Arthritis Treatment Market Attractiveness Analysis By Distribution Channel, 2018–2028

  137. Global Psoriatic Arthritis Treatment Market Value Analysis and Forecast, 2017–2028 (US$ Mn)

  138. Global Psoriatic Arthritis Treatment Market Absolute $ Opportunity (US$ Mn), 2017–2028